Need Help? Bulk Orders? Ordering by P.O. number? Contact Customer Service for further assistance. Phone: 1-314-971-3028 | Email: orders@mediomics.com

0
  • No products in the cart.

Bridge-It® Assay Platform Technology

Mediomics' novel DNA-binding protein assay design utilizes a two fluorophore system (a fluorophore donor and a fluorophore acceptor) in which the DNA fragment containing the binding site for the target protein is... [Read More]

TR-FRET Bridge-It® Assay Platform Technology

Mediomics' novel DNA-binding protein assay design utilizes a two fluorophore system (a fluorophore donor (Eu3+) and a fluorophore acceptor) in which the DNA fragment containing the binding site for the target protein is... [Read more]

FRET-Pincer® Assay Platform Technology

FRET-PINCER® Assays are a unique system to quantify the concentration of biomarkers, cells, and pathogens in a broad range of biological samples.  Mediomics’ PINCER® assay uses antibody binding specificity combined with... [Read More]

TRF-Pincer® Assay Platform Technology

TRF-PINCER® Assays are a unique system to quantify the concentration of biomarkers, cells, and pathogens in a broad range of biological samples.  Mediomics’ PINCER® assay uses antibody binding specificity combined with... [Learn More]

Exclusive Patent License

Mediomics, LLC holds an exclusive, worldwide license (with right to sublicense) for all possible commercial product applications covered by the claims of the issued and pending patents and patent applications invented in Dr. Tomasz Heyduk, Dr. Yie-Hwa Chang and Dr. David Waisman’s laboratories. This exclusive licensing agreement also provides to Mediomics an exclusive commercial license for all patents relating to the exclusively licensed patents, including any follow-on patents. Currently, Mediomics holds exclusive license for over 40 issued patents and pending patent applications (including any and all related patent filings).


Trademarks

The registered trademark, Bridge-It®, is owned by Mediomics. A trademark registration application for Mediomics trademark PincersTM is currently pending at the US-Patent and Trademark Office.